BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35351403)

  • 1. microRNA-150 targets major epigenetic repressors and inhibits cell proliferation.
    Selvam M; Bandi V; Ponne S; Ashok C; Baluchamy S
    Exp Cell Res; 2022 Jun; 415(1):113110. PubMed ID: 35351403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice.
    Grindheim JM; Nicetto D; Donahue G; Zaret KS
    Gastroenterology; 2019 May; 156(6):1834-1848. PubMed ID: 30689973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies.
    Nakagawa M; Kitabayashi I
    Cancer Sci; 2018 Aug; 109(8):2342-2348. PubMed ID: 29845708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
    Zhu WS; Tang CM; Xiao Z; Zhu JN; Lin QX; Fu YH; Hu ZQ; Zhang Z; Yang M; Zheng XL; Wu SL; Shan ZX
    Oncotarget; 2016 Nov; 7(48):78331-78342. PubMed ID: 27823969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
    Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
    Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6.
    Ashok C; Selvam M; Ponne S; Parcha PK; Raja KMP; Baluchamy S
    Med Oncol; 2020 Jul; 37(8):68. PubMed ID: 32710193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia.
    Johnstone AL; O'Reilly JJ; Patel AJ; Guo Z; Andrade NS; Magistri M; Nathanson L; Esanov R; Miller BH; Turecki G; Brothers SP; Zeier Z; Wahlestedt C
    Neurobiol Dis; 2018 Nov; 119():149-158. PubMed ID: 30099093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas.
    Yamagishi M; Hori M; Fujikawa D; Ohsugi T; Honma D; Adachi N; Katano H; Hishima T; Kobayashi S; Nakano K; Nakashima M; Iwanaga M; Utsunomiya A; Tanaka Y; Okada S; Tsukasaki K; Tobinai K; Araki K; Watanabe T; Uchimaru K
    Cell Rep; 2019 Nov; 29(8):2321-2337.e7. PubMed ID: 31747604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.
    Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B
    Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer.
    Wassef M; Luscan A; Aflaki S; Zielinski D; Jansen PWTC; Baymaz HI; Battistella A; Kersouani C; Servant N; Wallace MR; Romero P; Kosmider O; Just PA; Hivelin M; Jacques S; Vincent-Salomon A; Vermeulen M; Vidaud M; Pasmant E; Margueron R
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6075-6080. PubMed ID: 30867289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epigenetic aberrations in adult T-cell leukemia/lymphoma and development of a novel EZH1/2 inhibitor].
    Yamagishi M
    Rinsho Ketsueki; 2018; 59(4):432-438. PubMed ID: 29743404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo.
    Zhang Y; Liu F; Zheng J; Jiang K; Ai H; Liu L; Mao D
    Exp Cell Res; 2024 Feb; 435(1):113913. PubMed ID: 38199479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the Polycomb-Associated Methyltransferase Ezh2 during Maturation of Hippocampal Neurons Is Mediated by MicroRNAs Let-7 and miR-124.
    Guajardo L; Aguilar R; Bustos FJ; Nardocci G; Gutiérrez RA; van Zundert B; Montecino M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
    Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
    J Virol; 2019 May; 93(9):. PubMed ID: 30814291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
    Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
    Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
    [No Abstract]   [Full Text] [Related]  

  • 18. Polycomb repressive complex 2 regulates normal development of the mouse heart.
    He A; Ma Q; Cao J; von Gise A; Zhou P; Xie H; Zhang B; Hsing M; Christodoulou DC; Cahan P; Daley GQ; Kong SW; Orkin SH; Seidman CE; Seidman JG; Pu WT
    Circ Res; 2012 Feb; 110(3):406-15. PubMed ID: 22158708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-biased genetic programs in liver metabolism and liver fibrosis are controlled by EZH1 and EZH2.
    Lau-Corona D; Bae WK; Hennighausen L; Waxman DJ
    PLoS Genet; 2020 May; 16(5):e1008796. PubMed ID: 32428001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.